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ABSTRACT
Cockayne Syndrome (CS) is a severe neurodegen-
erative and premature aging autosomal-recessive
disease, caused by inherited defects in the CSA
and CSB genes, leading to defects in transcription-
coupled nucleotide excision repair (TC-NER) and
consequently hypersensitivity to ultraviolet (UV) ir-
radiation. TC-NER is initiated by lesion-stalled RNA
polymerase II, which stabilizes the interaction with
the SNF2/SWI2 ATPase CSB to facilitate recruitment
of the CSA E3 Cullin ubiquitin ligase complex. How-
ever, the precise biochemical connections between
CSA and CSB are unknown. The small ubiquitin-
like modifier SUMO is important in the DNA dam-
age response. We found that CSB, among an ex-
tensive set of other target proteins, is the most dy-
namically SUMOylated substrate in response to UV
irradiation. Inhibiting SUMOylation reduced the ac-
cumulation of CSB at local sites of UV irradiation
and reduced recovery of RNA synthesis. Interest-
ingly, CSA is required for the efficient clearance of
SUMOylated CSB. However, subsequent proteomic
analysis of CSA-dependent ubiquitinated substrates
revealed that CSA does not ubiquitinate CSB in a
UV-dependent manner. Surprisingly, we found that
CSA is required for the ubiquitination of the largest
subunit of RNA polymerase II, RPB1. Combined, our
results indicate that the CSA, CSB, RNA polymerase
II triad is coordinated by ubiquitin and SUMO in re-
sponse to UV irradiation. Furthermore, our work pro-
vides a resource of SUMO targets regulated in re-
sponse to UV or ionizing radiation.
INTRODUCTION
The integrity of DNA is continuously challenged by ex-
ogenous and endogenous DNA-damaging agents, such as
genotoxic chemicals, ionizing radiation (IR), ultraviolet
(UV) radiation or reactive oxygen species (ROS) (1). A
multitude of cellular mechanisms collectively called the
DNA damage response (DDR), ensure efficient responses
to genotoxic insults including recognition and repair of
DNA lesions. IR induces a set of different types of DNA
damage, including oxidized bases, single and double strand
breaks (DSBs). The latter are among the most cytotoxic
DNA lesions and are repaired by homologous recombina-
tion (HR), non-homologous end-joining (NHEJ) and alter-
native end-joining (Alt-EJ) (2–4).
UV induces cyclobutane pyrimidine dimers (CPD), a
photolesion with mild helix- distorting properties and 6-
4 photoproducts (6-4PP), a photolesion with strong helix-
distorting properties, that both strongly interfere with
DNA-transacting processes. In human skin cells, CPDs and
6-4PPs are exclusively removed by nucleotide excision repair
(NER). UV-induced photolesions in the transcribed strand
of actively transcribed regions are repaired by transcription-
coupled NER (TC-NER), whereas CPDs and 6-4PPs local-
ized throughout the genome are repaired by global genome
NER (GG-NER) (5). TC-NER and GG-NER differ in
their molecular recognition of the DNA lesion, but share
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the subsequent steps, including lesion verification, exci-
sion of 22–30 nucleotides around the lesion and gap fill-
ing by DNA synthesis. Proteins that are involved in DNA
repair pathways need to be tightly regulated to avoid in-
appropriate DNA processing. Post-translational modifica-
tions like phosphorylation, PARylation, ubiquitination and
SUMOylation play pivotal roles in this regulation (6).
Small Ubiquitin-like MOdifier (SUMO) is a 11 kDa pro-
tein that can be covalently attached to lysine residues in sub-
strate proteins via an enzymatic cascade, involving a het-
erodimeric SUMO activating E1 enzyme, a single SUMO
conjugating E2 enzyme and a limited number of SUMO
E3 ligases (7). SUMOylation is a highly dynamic process
due to the presence of SUMO specific proteases that can
reverse the SUMOylation of target proteins (8). Mammals
express at least three SUMO family members, SUMO1-
3, with SUMO2 being the most abundant and essential
member (9). Hundreds of target proteins are regulated by
SUMOs under both normal and cellular stress conditions
(10). The consequences of SUMOylation are specific for dif-
ferent target proteins and can include the alteration of in-
teractions with other proteins, the alteration of enzymatic
activity, or affecting substrate stability.
The first link between SUMOylation and DNA repair
was revealed in studies on base excision repair (BER),
where SUMOylation induces a conformational change in
the Thymine-DNA Glycosylase protein and thereby stimu-
lates the repair process (11,12). Furthermore, two SUMO
E3 ligases, PIAS1 and PIAS4, accumulate at DSBs. These
E3 ligases SUMOylate BRCA1 to induce its activity and
SUMOylation is required for the accumulation of different
repair components to facilitate repair of DSBs (13).
SUMO and ubiquitin also act together in the DDR,
best exemplified by the modification of the homo-trimeric,
ring shaped protein Proliferating Cell Nuclear Antigen
(PCNA). PCNA encircles DNA where it acts as a process-
ing factor for DNA polymerases and as an interaction plat-
form for proteins involved in DNA metabolism. Mono-
ubiquitination of PCNA on lysine 164 upon DNA damage
induces the recruitment of polymerases needed for transle-
sion synthesis, whereas SUMOylation on the same lysine
inhibits recombination during DNA synthesis by recruiting
the anti-recombinogenic helicase Srs2 (14,15). The role of
SUMO and ubiquitin crosstalk in DNA repair was further
emphasized by the observation that the SUMO-dependent
recruitment of RNF4, a well-studied SUMO-targeted ubiq-
uitin ligase (STUbL), to DSBs induces a ubiquitination sig-
nal that is essential for efficient repair of DSBs (16,17).
RNF111, another STUbL, was shown to regulate the
ubiquitination of XPC in GG-NER. XPC is part of the
GG-NER initiating XPC-RAD23-CETN2 DNA damage
recognizing complex. RNF111-mediated XPC ubiquitina-
tion is required for efficient progression of the NER re-
action by stimulating the handover of damaged DNA be-
tween XPC and the structure-specific endonucleases XPG
and ERCC1/XPF (18–20).
Ubiquitin also plays a pivotal role in the regulation
of TC-NER. Two key factors in TC-NER are Cockayne
Syndrome (CS) gene products CSA and CSB. CS is an
autosomal-recessive disease and patients display severe
neurodegeneration and premature aging. CSA- and CSB-
deficient cells are both impaired in TC-NER and conse-
quently hypersensitive to UV irradiation. TC-NER is ini-
tiated by stalling of RNA polymerase II at lesions, stabi-
lizing the interaction with the SNF2/SWI2 ATPase CSB
to facilitate recruitment of the CSA protein. CSA is part
of an E3 Cullin ubiquitin ligase complex. CSA was pro-
posed to ubiquitinate and destabilize CSB (21). UVSSA, a
more recently identified player in TC-NER, was shown to
counteract this CSA-dependent destabilization of CSB by
recruiting the deubiquitinating enzyme USP7 (22,23). Ad-
ditionally, the UV-induced ubiquitination of the elongating
RNA polymerase II (RNAPIIo) is dependent on UVSSA
(24). Collectively, these data indicate a pivotal role for post-
translational modifications during the DNA damage re-
sponse.
Here. we set out to investigate potential biochemical con-
nections between CSA and CSB. In our hands, CSA did
not act as a ubiquitin E3 ligase for CSB in a UV-regulated
manner. In contrast, we found that the ubiquitination of
RNAPIIo is regulated by the CSA complex in response to
UV. Furthermore, we found that CSB is the most strongly
regulated substrate for the ubiquitin-like protein SUMO2
in response to UV. Clearance of SUMOylated CSB was de-
pendent on CSA. Our data indicate that SUMOylated CSB,
CSA and ubiquitinated RNAPIIo are connected and func-
tion together to promote efficient TC-NER.
MATERIALS AND METHODS
Detailed information on antibodies, oligonucleotides,
reagents and databases used can be found in Supplemen-
tary Table S5.
Plasmids
Expression constructs for CSB K32R, K205R, 2KR and
5KR were generated by site-directed mutagenesis using the
pDONR207-CSB wild-type (WT) plasmid as a template.
Resulting CSB mutants and WT construct were cloned
into pLX303 destination vector for lentiviral transduc-
tion (Addgene plasmid #25897), into pBabe-puro-GFP-
DEST destination vector (kind gift of Dr Marc Timmers,
Freiburg, Germany) for retroviral transduction or into
pDEST-EGFP-C1 destination vector for transient trans-
fection, using Gateway cloning technology (Thermo Fisher
Scientific). To create a truncated CSB mutant, a cDNA en-
coding amino acids 1 until 341 of CSB was cloned into
pDONR207. For bacterial expression of this CSB fragment,
this construct was subsequently cloned into pDEST15 us-
ing Gateway cloning technology. Epitope-tagged CSA has
been described previously (25).
Cell lines, SILAC labelling and generation of cell lines
U2OS, hTERT1 immortalized RPE1 cells and sv40 immor-
talized CS1AN (a CSB patient cell line), CS3BE (a CSA
patient cell line) and VH10 cells were cultured in Dul-
becco’s modified Eagle’s medium supplemented with 10%
FCS and 100 U/ml penicillin and 100 g/ml streptomycin.
For stable isotope labelling by amino acids in cell culture
(SILAC), cells were essentially labelled as described before
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(26). Briefly, cells were grown inmedium supplementedwith
[13C6, 14N4] arginine (referred to as Arg6), [13C6, 15N4] argi-
nine (referred to as Arg10), [2H4, 13C6, 14N2] lysine (referred
to as Lys4), [13C6, 15N2] lysine (referred to as Lys8) as indi-
cated.
U2OS cell lines stably expressing Flag-SUMO2, His10-
SUMO2 or His10-ubiquitin were previously described
(27,28). U2OS His10-SUMO2-IRES-GFP cells expressing
GFP-CSB WT and mutants were generated by infecting
cells with retrovirus encoding the different pBabe-GFP-
CSB constructs together with a Puromycin resistance gene.
Cells were selected for GFP-CSB expression by culturing in
medium supplemented with 1 g/ml Puromycin. CS1AN
cell lines co-expressingHis10-SUMO2 and tagless CSBWT
and mutants were generated by an initial round of infection
of cells with lentivirus encoding a His10-SUMO2-IRES-
puro construct and Puromycin selection (1 g/ml) and a
subsequent round of infection with lentivirus encoding the
different pLX303-CSB mutant constructs. Cells were se-
lected for CSB expression by culturing in medium supple-
mented with 5 g/ml Blasticidin. CS1AN cells stably ex-
pressing EGFP-CSB WT or mutants were generated by
transfecting cells with pDEST-EGFP-CSB constructs also
encoding a Neomycin resistance gene. Monoclonal cell cul-
tures were selected with 400 g/ml G418 (Neomycin) and
were selected by flow cytometry based onEGFP expression.
U2OS Flp-In/T-REx cells, which were generated
using the Flp-In™/T-REx™ system (Thermo Fisher
Scientific), were a gift of Daniel Durocher. These cells
were co-transfected with pLV-U6g-PPB containing an
antisense guide RNA targeting the CSA/ERCC8 gene
(5’-CCAGACTTCAAGTCACAAAGTTG-3’) from the
Sigma-Aldrich sgRNA library together with an expres-
sion vector encoding Cas9-2A-GFP (pX458; Addgene
#48138). Transfected U2OS Flp-In/T-REx were selected
on puromycin (1 g/ml) for 3 days, plated at low density
after which individual clones were isolated. Knockout
of CSA in the isolated clones was verified by sequencing
of genomic DNA by nested PCR using the following
primers: 5’-CAGTCTGTGTCCAGTTTCTGTG-3’,
5’-CATATTTGTTATGTGTTTCTTTGAG-3’, 5’-
GTACATACATACATACACATTTACCAATAC-3’, and
5’-CTGAGAAAAAATGTACCTAAATATTAAG-3’, as
well as by immunoblot analysis (Rabbit -CSA/ERCC8,
EPR9237, Abcam 137033). The absence of Cas9
integration/stable expression was confirmed by im-
munoblot analysis (Mouse -Cas9, 7A9-3A3, #14697,
Cell Signaling Technology). CS3BE cells stably expressing
His-CSA were generated by infecting cells with lentiviruses
encoding CSA and the Blasticidin resistance gene. After
infection, cells were selected for expression of CSA by
culturing in medium supplemented with 5 g/ml Blas-
ticidin. RPE1 cell lines immortalized by hTERT1 and
expressing inducible shRNA against UBA2/SAE2 were
generated by infecting cells with lentiviruses encoding the
different shRNA constructs and a Neomycin resistance
cassette. Cells were selected for expression of the introduced
construct by selection with 400 g/ml G418.
For the induction of different DNA lesions 50Metopo-
side (Sigma Aldrich) was used in culture medium for 1 h,
0.02% methyl methanesulfonate (MMS) (Sigma Aldrich)
was used in culture medium for 1.5 h, 2 mM hydroxyurea
(HU) (Sigma Aldrich) was used in culture medium for 2
or 24 h. Cells were treated with 4 Gy of IR and 20 J/m2
UV-C light and lysed after the indicated recovery times.
100 M 5,6-dichlorobenzimidazole 1--D-ribofuranoside
(DRB) (Sigma Aldrich) was used in culture medium for 3
h prior to UV irradiation. 2 g/ml -amanitin (HY-19610,
MedChemExpress and A2263-1MG Sigma Aldrich) was
used in culture medium for 24 h prior to UV irradiation.
Live imaging experiments, UV-C irradiation
Localisation studies of GFP-CSB were performed using
UV-C (266 nm) laser-irradiation for local DNA damage
infliction (29). Briefly, a 2-mW pulsed (7.8 kHz) diode-
pumped solid-state laser emitting at 266 nm (Rapp Opto-
Electronic) was connected to the confocal microscope Leica
TCS SP5 AOBS with an Axiovert 200M housing adapted
for UV by all-quartz optics. By focusing the UV-C laser in-
side cell nuclei without scanning, only a limited area within
the nucleus (diffraction limited spot) was irradiated. Cells
were imaged and irradiated through a 100×, 1.2 NA Ul-
trafluar quartz objective lens. Images obtained prior to and
post UV-C laser irradiation were analysed using the LAS
AF software (Leica).
Purification of His10 conjugates using Ni-NTA beads
His10-ubiquitin conjugates and His10-SUMO2 conju-
gates were purified using nickel-nitrilotriacetic acid-agarose
beads (Ni-NTA)(Qiagen) as previously described (30). In
brief, cells stably expressing His10-SUMO2 or His10-
ubiquitin were lysed in 6 M guanidine–HCl pH 8.0. Small
fractions of cells were separately lysed in SNTBS buffer (2%
SDS, 1% N-P40, 50 mM Tris pH 7.5 and 150 mMNaCl) as
input controls. After sonication and addition of imidazole
(50 mM) and ß-mercaptoethanol (5 mM), lysates were in-
cubated with pre-washed Ni-NTA beads. After incubation,
beads were washed subsequently with buffers 1–4. Wash
Buffer 1: 6M guanidine–HCl, 0.1MNa2HPO4/NaH2PO4,
pH 8.0, 10 mMTris–HCl pH 8.0, 10 mM imidazole pH 8.0,
5 mM ß-mercapthoethanol and 0.1% Triton X-100 (0.2%
Triton X-100 for immunoblotting sample preparation).
Wash Buffer 2: 8 M urea, 0.1 M Na2HPO4/NaH2PO4, 10
mM Tris–HCl pH 8.0, 10 mM imidazole pH 8.0, 5 mM ß-
mercaptoethanol and 0.1% Triton X-100 (0.2% Triton X-
100 for immunoblotting sample preparation). Wash Buffer
3: 8 M urea, 0.1 MNa2HPO4/NaH2PO4, 10 mM Tris–HCl
pH 6.3, 10mM imidazole pH 7.0, 5mMß-mercaptoethanol
and no Triton X-100 (0.2% Triton X-100 for immunoblot-
ting sample preparation). Wash Buffer 4: 8 M urea, 0.1 M
Na2HPO4/NaH2PO4, 10 mM Tris–HCl pH 6.3, 5 mM ß-
mercaptoethanol and no Triton X-100 (0.2% Triton X-100
for immunoblotting sample preparation). Elution of sam-
ple was performed twice in one bead-volume of 7 M urea,
0.1 M Na2HPO4/NaH2PO4, 10 mM Tris–HCl pH 7.0 and
500 mM imidazole pH 7.0.
Electrophoresis and immunoblotting
To visualize CSB and RPB1 by immunoblotting, either
6% Tris-glycine gels or Novex 3–8% Tris-acetate gradient
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gels (Thermo Fisher Scientific) were used for electrophore-
sis. To visualize other proteins, samples were separated on
Novex 4–12% Bis–Tris gradient gels (Thermo Fisher Sci-
entific) with MOPS buffer or via regular SDS-PAGE using
Tris-glycine gels. Separated proteins were transferred onto
Amersham Protran Premium 0.45 NC nitrocellulose blot-
ting membrane (GE Healthcare) using a submarine sys-
tem. For whole cell lysates, membranes were stained with
Ponceau S (Sigma) as loading control. Membranes were
blocked with 8% non-fat milk in PBS 0.05% Tween for 1
h, prior to primary antibody incubation.
RNA synthesis recovery assay
Two independent doxycycline (Dox)-inducible shRNAs
against UBA2 and a non-targeted control shRNA (31) were
stably expressed in RPE1 cells. Cells were seeded in 96-
well plates and the knockdown was induced by Dox treat-
ment. Cells were irradiated with UV-C (10 J/m2), and sub-
sequently cultured for the indicated time-periods (0–24 h)
to allow RNA synthesis recovery. RNA was labelled for 1 h
in medium supplemented with 1 mM EU (Click-iT® RNA
Alexa Fluor® 594 Imaging Kit, Life Technologies) accord-
ing to the manufacturer’s instructions. Imaging was per-
formed on anOpera Phenix confocal High-Content Screen-
ing System (Perkin Elmer, Hamburg, Germany) equipped
with solid state lasers. General nuclear staining (DAPI) and
Alexa 594 were serially detected in nine fields per well using
a 20× air objective. Three independent experiments were
analysed using a custom script in the Harmony 4.5 software
(Perkin Elmer) in which nuclei were individually segmented
based on the DAPI signal. RNA synthesis recovery was de-
termined by measuring the mean Alexa 594 intensity of all
nuclei per field.
Proteomics sample preparation and mass spectrometry
His10-purified samples were supplemented with ammo-
nium biocarbonate (ABC) to 50 mM. Subsequently sam-
ples were reduced with 1 mM dithiothreitol (DTT) for 30
min and alkylated with 5 mM chloroacatemide (CAA) for
30 min and once more reduced with 5 mMDTT for 30 min
at room temperature. Proteins were digested with Lys C for
3 h in a 1:100 enzyme-to-protein ratio. Subsequently the
peptides were diluted 4-fold with 50 mM ABC and trypsin
digested overnight in a 1:100 enzyme-to-protein ratio.
Mass spectrometry
Samples were acidified and subsequently desalted and con-
centrated on triple-disc C18 reverse phase StageTips (32).
Peptides were eluted twice, with 40% and 60% acetonitrile
(ACN) in 0.1% formic acid, respectively. Peptides were vac-
uum centrifuged until all liquid was evaporated and re-
suspended in 0.1% formic acid. Peptides were analysed by
mass spectrometry using a Q-Exactive Orbitrap (Thermo
Fisher Scientific) coupled to an EASY-nLC system (Prox-
eon).
Processing of mass spectrometry data
MaxQuant (version 1.5.3.30) was used to analyse RAW
data. The MaxQuant output protein groups table was fur-
ther analysed using Perseus software (version 1.5.3.1). Data
were filtered by removing ‘reverse identified’, ‘only identi-
fied by site’ and ‘potential contaminants’. LFQ intensities
were log2 transformed. The following groups were compiled
from the three biological replicates: U2OS 1 h IR, U2OS 1
h UV, U2OS-His10-SUMO2 mock treated, U2OS-His10-
SUMO2 1 h IR, U2OS-His10-SUMO2 6 h IR, U2OS-
His10-SUMO2 1 h UV, U2OS-His10-SUMO2 6 h UV.
Protein groups that had at least three valid values in at
least one group were selected for further analysis. Miss-
ing values were imputed using Perseus software by nor-
mally distributed values with a 1.8 downshift (log2) and
a randomized 0.3 width (log2) considering the whole ma-
trix. Subsequently, two-sample t-tests were conducted be-
tween different experimental conditions (two-sided). Pro-
teins that showed a log2 difference of >0.66 and a P-value
of <0.05 at least in one His10-SUMO2 purified condition
compared to the U2OS parental control were selected as
SUMO2 target proteins. IR-induced SUMO2 targets 1 h
or 6 h post-IR needed a log2 difference of >0.66 and a P-
value of<0.05 comparedwithHis10-SUMO2mock treated
control and parental U2OS 1 h IR conditions. UV-induced
SUMO2 targets 1 h or 6 h post-UV needed a log2 differ-
ence of>0.66 and aP-value of<0.05 comparedwithHis10-
SUMO2 mock treated control and parental U2OS 1 h UV
condition.
Identification of proteins that bind to SUMOylated CSB
Escherichia coli strain BL21 was co-transformed with a
plasmid encoding theGST-CSBN-terminus (aa 1–341) and
a plasmid encoding the SUMO2 conjugation machinery
(33). Expression of transgenes was induced by 0.5 mM
IPTG at 25◦C overnight. Bacteria were harvested by cen-
trifugation, washed twice with icecold PBS before resus-
pending in PBS, 0.5 M NaCl, 1 mM PMSF and cOm-
plete™ mini protease inhibitor cocktail (Sigma). Cells were
lysed by sonification and the addition of 10% Triton X-100.
Lysates were cleared by centrifugation at 13 000 rcf and su-
pernatant was incubated with glutathione Sepharose beads
(GE Healthcare) for 2 h at 4◦C. After incubation, beads
were washed twice with PBS, 0.5 M NaCl,1 mM PMSF
and cOmplete™, mini protease inhibitor cocktail (Sigma)
and washed three times with 50 mM Tris pH 7.5, 0.5 M
NaCl. Each sample was equally divided over two new re-
action tubes and one half was treated with 10 g of recom-
binant SENP2 overnight at 4◦C. Beads were washed three
times with 50mMTris pH 7.5 and 0.5MNaCl, thenwashed
twice with 50 mM Tris pH 7.5, 150 mM NaCl, 0.5% NP-
40, 1 mMMgCl2, 20 mM NEM and cOmplete™, mini pro-
tease inhibitor cocktail (Sigma) before incubation with cell
lysates.
For the preparation of the cell lysates, CS1AN cells were
irradiated with UV-C at 20 J/m2 and lysed 1 h after UV
treatment in lysis buffer (50mMTris pH 7.5, 150mMNaCl,
0.5% NP-40, 1 mMMgCl2, 20 mM NEM and cOmplete™,
mini protease inhibitor cocktail (Sigma)). Cells were soni-
cated and treated with 500 U/ml benzonase for 1 h at 4◦C.
Cleared cell lysate was incubated with previously prepared
glutathione Sepharose containing SUMOylated GST-CSB,
de-SUMOylated GST-CSB or GST only for 2 h at 4◦C.
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After incubation, beads were washed four times with lysis
buffer, subsequently three times in 50 mM fresh ammonium
bicarbonate (ABC) and bound proteins were trypsinized
with 2 g trypsin overnight at 37◦C.
Flag-SUMO2 and Flag-Ubiquitin immunoprecipitation
Flag-SUMO2 and Flag-Ubiquitin conjugates were en-
riched by anti-Flag immunoprecipitation as described pre-
viously (27).
RESULTS
Identification of SUMOylated proteins in response to IR- or
UV-induced DNA damage
We set out to identify dynamic SUMO2 target proteins that
are involved in the DDR, employing an unbiased quanti-
tative proteomics approach that we previously developed
(30). We have focussed on SUMO2 since this is the most
abundant mammalian SUMO family member (9). Prolifer-
ating U2OS cells stably expressing His10-SUMO2 were ir-
radiatedwith either 20 J/m2 UV-light or 4Gy of IR ormock
treated (untreated control). Moreover, parental U2OS cells
were irradiatedwith eitherUVor IR as control for a-specific
binding to the Ni-NTA beads. Parental U2OS cells were
lysed after 1 h recovery upon DNA damage induction and
U2OS His10-SUMO2 cells were lysed after 1 or 6 h recov-
ery upon DNA damage induction. SUMOylated proteins
were subsequently purified, trypsin digested and peptides
were analysed by mass spectrometry (Figure 1A). We veri-
fied the efficiency of SUMOenrichment by immunoblotting
(Figure 1B).
Label free quantification of proteins that were identi-
fied by mass spectrometry revealed 513 putative SUMO2
targets (Supplementary Table S1). Strikingly, significantly
more proteins were modified by SUMO2 in response to UV
compared to IR. After 1 h recovery post-UV irradiation we
identified 30 proteins that showed increased SUMOylation
compared to the mock treated control and this number in-
creased to 58 proteins at 6 h recovery post-UV irradiation.
Twenty one proteins showed enhanced SUMOylation after
1 h recovery post-IR and after 6 h recovery post-IR as few
as five proteins showed increased SUMOylation compared
to the mock treated control (Figure 1C, Supplementary Ta-
ble S2). The DNA damage-checkpoint protein MDC1 was
identified as SUMO2 target protein in all conditions (Fig-
ure 1D and E), in line with earlier observations (34) and
thus served as a positive control. XPC SUMOylation in re-
sponse to UV (Supplementary Figure S1) likewise served as
a positive control (18).
We also observed that 41 out of 58 proteins that showed
increased SUMOylation 6 h after UV irradiation were nei-
ther SUMOylated after 1 h recovery upon UV damage
nor in response to IR-induced damages (Figure 1E, Sup-
plementary Table S2), showing that they were specifically
targeted for SUMOylation at a later time point after UV
damage. Our data demonstrate that UV-induced DNA le-
sions activate a unique and more pronounced SUMOyla-
tion response compared to IR, indicating important roles
of SUMOylation during cellular responses to UV lesions at
early and later stages.
STRING network analysis of SUMO2 targets identified
after 6 h recovery upon UV irradiation, revealed intercon-
nected groups of proteins. We identified functional clusters
of proteins involved in the DNA damage response, tran-
scription, the SUMO pathway, ribosomal biogenesis and
RNA processing. Interestingly, amongst the proteins asso-
ciated with transcription we identifiedmultiple components
of the TFIIDbasal transcription factor complex (Figure 1F,
Supplementary Table S2).
UV-induced SUMOylation of CSB is dependent on transcrip-
tion and located at the N-terminus
The most dynamic SUMO2 target protein that we iden-
tified was CSB, showing a massive ∼1000-fold increase
in SUMOylation specifically upon UV-induced damage at
both recovery time points, but not in response to IR (Figure
1D). Since CSB is a crucial player in the TC-NER pathway,
we chose to investigate the function of CSB SUMOylation
in more detail. Since UV is known to strongly inhibit tran-
scription elongation whereas IR hardly does, it is likely that
particularly lesion-stalled transcription complexes trigger
CSB SUMOylation. We explored a wider range of DNA-
damaging agents for their ability to induce CSB SUMOy-
lation and found that SUMOylation of CSB is also in-
duced by methyl methanesulfonate (MMS) and etoposide
in addition to UV (Figure 2A). Etoposide is also an in-
hibitor of transcription elongation and consistently induced
CSB SUMOylation (Figure 2A). Furthermore, MMS in-
duced CSB SUMOylation, which could indicate that the
concentration and duration of the MMS treatment likewise
resulted in stalling of transcription. These agents also in-
duce transcription-blocking DNA lesions that can be re-
paired byTC-NER (35,36). Other types ofDNA lesions like
hydroxyurea-induced replication stress or IR-induced dou-
ble strand breaks (DSBs), did not stimulate the SUMOyla-
tion of CSB (Figure 2A).
Subsequently, we tested whether CSB SUMOylation was
dependent on active transcription and on the stalling of
RNAPIIo at the lesion. To evaluate this, we treated U2OS
His10-SUMO2 cells with DRB or -amanitin, two potent
inhibitors of RNAPII (37), prior to induction of DNA le-
sions by UV irradiation. -amanitin interferes with a con-
formational change of RPB1 underlying the transcription
mechanism; therefore, it inhibits elongation. DRB inhibits
CDK-Activating Kinase (CAK), which is associated with
TFIIH, and thereby blocks transcription initiation. DRB
treatment reduced phosphorylated RPB1 (p-RPB1) and to-
tal RPB1 as expected and the reduction in p-RPB1 in re-
sponse to -amanitin is due to a striking reduction in to-
tal amount of RPB1 (Figure 2B). We observed that UV-
induced SUMOylation of CSB was decreased in cells that
were pre-treated with these inhibitors. Blocking either initi-
ation or elongation of transcription did itself not result in
CSB SUMOylation (Figure 2B), indicating that transcrip-
tion and the stalling of RNAPIIo at the lesion are prereq-
uisites for CSB SUMOylation.
In order to investigate the role of CSB SUMOylation
during the UV response, we aimed to identify the SUMO
target lysines of CSB. CSB is a 1493 aa protein that in-
cludes five lysines embedded in SUMOylation consensus
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Figure 1. Identification of SUMOylated proteins in response to IR- or UV-induced DNA damage. (A) Experimental set-up. U2OS cells stably expressing
His10-SUMO2 or parental cells were irradiated with ultraviolet light (UV) (20 J/m2) or ionizing radiation (IR) (4 Gy) or were mock treated. Cells were
lysed 1 h or 6 h after DNA damage induction and SUMOylated proteins were purified by means of Ni-NTA pulldown. Purified proteins were trypsin
digested and peptides were analysed by mass spectrometry. (B) Total lysates and His10-SUMO2 purified fractions were analysed by immunoblotting using
a specific antibody against SUMO2/3. (C) The experiment, as described in (A) was performed in triplicate and protein groups were selected. SUMOylated
proteins required a minimal fold change of 1.5 with a P-value <0.05 in at least one of the U2OS His10-SUMO2 conditions compared to the parental
control. SUMO2 targets after 1 or 6 h IR or UV damage required a minimal fold change of 1.5 with a P-value <0.05 compared to the His10-SUMO2
expressing control that was mock treated. (D) Volcano plots showing all identified proteins. Dashed lines indicate a cut-off of 1.5-fold change (log2 of 0.66)
and a P-value of 0.05 (–log10 of 1.3). Selected SUMO2 targets are marked in a red and display a label. (E) Venn diagram showing overlap of SUMO2
targets in different conditions. (F) Protein interaction network based on the STRING database showing connections between SUMO2 targets identified 6
h after UV irradiation with a medium confidence level of 0.4. Increased node size represents increased log2 fold change in LFQ intensities relative to mock
treated control. Colours of nodes indicate main functional groups.
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Figure 2. UV-induced SUMOylation of CSB is dependent on transcription and located at the N-terminus. (A) U2OS cells stably expressingHis10-SUMO2
were left untreated or were treated with either DMSO, or 0.02% MMS, 50 M etoposide, 2 mM hydroxyurea, 4 Gy IR or 20 J/m2 UV. Times indicate
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motifs, which are characterized by a large hydrophobic
residue () upstream, and a glutamic acid two positions
downstream of the lysine (KxE) (Figure 2C). We con-
structed lysine to arginine point mutants to disrupt po-
tential SUMOylation sites in GFP-tagged CSB, starting
from the most C-terminal lysine and mutating upstream
SUMOylation motifs consecutively. Next, we compared
SUMOylation levels of the different CSB mutants after
UV irradiation by exogenous expression in U2OS His10-
SUMO2 cells. Mutating the three most distal potential
SUMOylation sites (K481,1359,1489R) did not strongly af-
fect UV-induced CSB SUMOylation. However, adding the
more N-terminal mutation K205R caused a pronounced
SUMOylation decrease (Figure 2D). We expected that
the residual SUMOylation of the CSB quadruple mutant
(K205,481,1359,1489R) was located at position K32. Mu-
tating both N-terminal lysine (2KR) or all five consensus
sites (5KR) led to a complete loss of UV-induced SUMOy-
lation (Supplementary Figure S2).
To further investigate the SUMO acceptor sites of
CSB, we generated single mutants for K205R and K32R
in addition to 2KR (K205R and K32R) and 5KR
(K32,205,481,1359,1489R) mutants. These mutants, to-
gether with a His10-SUMO2 construct, were expressed in
the CSB-deficient patient cell line, CS1AN (Figure 2E).
Mutating either one of the N-terminal lysines (K32 or
K205) resulted in a significant reduction of CSB SUMOy-
lation when corrected for exogenous expression levels, al-
though uncorrected SUMOylation levels were lower in the
K205R mutant than in the K32R mutant. The CSB 5KR
mutant showed a pronounced additive reduction in CSB
SUMOylation levels (Figure 2E and F). Collectively, our
results show that CSB is predominantly SUMOylated at
two N-terminal lysine residues and that CSB SUMOyla-
tion is dependent on active transcription and the stalling
of RNAPIIo at the lesion.
SUMOylation is necessary for efficient recruitment of CSB
toUV-damagedDNAand for transcription recovery afterUV
damage
Next, we aimed to evaluate if SUMOylation is needed for
efficient transcription recovery after UV-induced lesions,
which is dependent on functional TC-NER. To address this,
we made use of RPE1 cells harbouring inducible shRNAs
targeting the SUMO E1 subunit UBA2, to reduce global
SUMOylation levels (Supplementary Figure S3). We mea-
sured the relative amount of RNA synthesis, represented
by the incorporation of 5-ethynyl-uridine (EU) into nascent
RNA, after UV irradiation in cells with reduced SUMOy-
lation levels. Shortly after irradiation the RNA synthesis
dropped due to stalling of elongating RNA polymerases
(RNAPIIo). In wild-type human cells with fully functional
TC-NER, lesions are efficiently repaired and UV-inhibited
RNA synthesis resumes in a time-dependent manner (38),
frequently via re-initiation of RNA synthesis (39). Con-
trary, CS cells with defective TC-NER are incapable of
restoring UV-inhibited RNA synthesis. We observed that
reduction of SUMOylation, due to the induced knockdown
of UBA2, had no impact on the UV-induced inhibition of
transcription but merely delayed the recovery of RNA syn-
thesis (RRS) after UV irradiation (Figure 3A), demonstrat-
ing a role for SUMOylation in the transcription recovery
after UV damage, most likely facilitating the repair of UV-
induced lesions or stimulating transcriptional restart.
Subsequently, we tested whether this delay in RRS af-
ter UV irradiation upon UBA2 knockdown could be at-
tributed to lack of SUMOylation of CSB. For this pur-
pose, we employed CS1AN cells, the CSB-deficient patient
cell line. We re-introduced GFP-tagged wild-type CSB or a
double mutant of CSB (K32,205R: 2KR), lacking the main
SUMOylation sites (Supplementary Figure S2). Cells ex-
pressing CSB 2KR showed a statistically significant reduc-
tion in RRS 24 h after UV irradiation (Figures 3B and S4),
indicating that CSB SUMOylation contributes to the delay
in RRS upon UBA2 knockdown (Figure 3A).
To gain more insight into the role of CSB SUMOyla-
tion during the cellular response to UV irradiation, we next
investigated the recruitment of the SUMOylation-mutants
of CSB to locally induced UV lesions in living cells (Fig-
ure 3C). For this purpose, we fused CSBWT, CSBK32R,
CSBK205R and CSB2KR to GFP, induced local UV dam-
age using a UV-C laser and measured the recruitment ki-
netics of GFP-CSB to the damage site (22,29). Four repli-
cates showed a reduced recruitment of the CSBK205R mu-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
treatment period of cells with the compound before lysis. For IR and UV treated cells, times represent recovery period after treatment. SUMO2 conjugates
were enriched by Ni-NTA pulldown (PD). Total lysates and SUMO2-enriched fractions were analysed by immunoblotting using antibodies against CSB
or SUMO2/3. MMS, methyl methanesulfonate; IR, ionizing radiation; UV, ultraviolet light irradiation. (B) U2OS cells stably expressing His10-SUMO2
were treated with DRB or -amanitin and/or UV irradiation (20 J/m2). Times indicate treatment period with the compound before lysis. For irradiation,
these times indicate recovery period after irradiation prior to lysis. For the DRB and UV irradiated sample, cells were treated with DRB 3 h prior to
UV irradiation and lysed 30 min after the UV treatment. For -amanitin and UV irradiated samples, cells were treated 24 h prior to UV irradiation and
lysed 30 min after UV treatment. SUMO2 conjugates were enriched by Ni-NTA pulldown. Total lysates and SUMO2-enriched fractions were analysed
by immunoblotting using antibodies against CSB, p-RPB1 (S2/S5), RPB1, or SUMO2/3. DRB, 5,6-dichlorobenzimidazole 1--D-ribofuranoside. (C)
Schematic overview of CSB including known domains and localization of SUMOylation consensus sites (KXE). (D) U2OS cells stably expressing Flag-
SUMO2 were infected with retroviruses encoding different SUMOylation consensus site mutants of GFP-CSB, as indicated. Cells were treated with UV
irradiation (20 J/m2) and lysed after 1 h recovery. SUMO2 conjugates were enriched by Flag IP. Total lysates and SUMO2-enriched fractions were analysed
by immunoblotting using antibodies against GFP or SUMO2/3. (E) CS1AN cells stably expressingHis10-SUMO2were infected with lentiviruses encoding
different CSB SUMOylation consensus site mutants. Cells were treated with UV irradiation (20 J/m2) and lysed after 30 min recovery. SUMO2 conjugates
were enriched by Ni-NTA pulldown. Total lysates and SUMO2-enriched fractions were analysed by immunoblotting using antibodies against CSB or
SUMO2/3. * marks the exogenously expressed CSB construct. ** marks the CSB-piggyBac transposable element derived three fusion (CPFP) (57). K32,
205R (2KR); K32, 205, 481, 1359, 1489R (5KR). (F) Quantification of (E). Relative amount of SUMOylated CSB was determined based on immunoblots.
Intensities were corrected for exogenous CSB expression levels (see * in E) and protein loading as determined by expression of CPFP (** in E) and Ponceau
S stain. Values were normalized to CSB WT SUMOylation. Error bars represent SD of the mean obtained from three independent experiments *P-value
<0.05; ** P-value <0.01; *** P-value <0.001 (two-sided).
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Figure 3. SUMOylation is necessary for efficient transcription recovery after UV damage and for efficient recruitment of CSB to UV-damaged DNA. (A)
Two independent doxycycline (Dox)-inducible shRNAs against UBA2 and a non-targeted control shRNAwere stably expressed in RPE1 cells. Knockdown
was induced by Dox and cells were treated with 10 J/m2 UV. Relative RNA synthesis was measured by incorporation of EdU, prior to UV, and at 2, 6
and 24 h post-UV irradiation. Error bars represent SD of the mean of three independent experiments. Data were analysed by one-way Anova followed
by a Tukey’s multiple comparison test. **** represents P-value <0.0001. (B) The experiment described in A was repeated, using CSB-deficient patient
cells (CS1AN) without rescue, or expressing GFP-tagged CSB wild-type (WT) or 2KR mutant (K32R, K205R) and VH10 cells. Recovery times after UV
irradiation are indicated. All datapoints, average RRS and SD for triplicate experiments are shown. Data were analysed by one-way Anova followed by a
Tukey’s multiple comparison test. **** represents P-value <0.0001. (C–E) Accumulation kinetics of fluorescent intensities at locally induced UV damage
of GFP-CSBWT and mutants expressed in CS1AN cells. Relative fluorescence was measured in the local damage area and in a non-treated area in the cell
nucleus as shown in C. Results shown are the means of four independent experiments. Error bars represent the SD. Panel D shows kinetics of CSB WT,
CSB K205R and CSB 2KR (K32R, K205R). Panel E shows kinetics of CSB WT and CSB K32R.
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tant compared toCSBWT (Figure 3D).Unlike the CSBK205R
single mutant, the CSBK32R mutant doesn’t seem to have
any obvious defect in recruitment to the local damage sites
(Figure 3E). Interestingly, the CSB2KR mutant showed a
more pronounced impairment of recruitment that might in-
dicate a functional contribution of CSBK32 SUMOylation
in the absence of CSBK205 SUMOylation (Figure 3D and
E). Collectively, we showed that SUMOylation is needed
for efficient transcription recovery after UV irradiation and
that decreased CSB SUMOylation impairs the recruitment
and/or stabilization of CSB at the damage site.
SUMOylation ofCSB influences binding toRNApolymerase
associated proteins
Our results described in the previous section could po-
tentially be explained by a SUMOylation-dependent al-
teration of CSB protein interactions. SUMOylation is a
low stoichiometric post-translational modification, mak-
ing it difficult to study direct protein interactions in vivo.
Therefore, we have used a strategy to study SUMOylation-
dependent alterations in protein interactions of CSB us-
ing an in vitro approach (33). Since the main UV-induced
SUMOylation sites were located in the N-terminal part
of CSB, we focussed on this part of the protein. We co-
transformed E.coli with a plasmid encoding GST-tagged
CSB truncation mutant (aa 1–341) and a plasmid encod-
ing the SUMOylation machinery and subsequently purified
the SUMOylated truncated CSB protein (SUMO-CSB). To
ensure the same amounts of CSB protein in the SUMOy-
lated and non-SUMOylated sample, we equally divided the
purified SUMO-CSB sample and deSUMOylated one half
by adding recombinant sentrin/SUMO-specific protease 2
(SENP2). SUMOylation and deSUMOylation of CSBwere
confirmed by immunoblotting (Supplementary Figure S5).
We included a third sample with GST-only as negative con-
trol (Figure 4B). GST, SUMO-CSB and CSB were subse-
quently incubated with a lysate of UV-irradiated CS1AN
cells. After incubation, beads were washed and purified pro-
teins were trypsin-digested on the beads. Interactomes were
analysed using mass spectrometry (Figure 4A and B).
We selected differentially binding proteins based on the
fold change and P-value of their abundances in the SUMO-
CSB sample compared to unmodified CSB. Proteins that
showed no differential binding compared to the GST con-
trol were excluded. The presence of SUMO2 as the most
significant and enriched protein identified, confirmed and
validated the approach (Figure 4D). Of the 641 proteins
identified, 46 proteins co-enriched with CSB irrespective of
SUMOylation, compared with the GST control (Figure 4C
and E, Supplementary Table S3). 25 proteins showed in-
creased binding to SUMO-CSB compared to unmodified
CSB, whereas 23 proteins showed preferential binding to
unmodified CSB compared to SUMO-CSB (Figure 4C and
D, Supplementary Table S3). Within the protein group that
co-enriched with SUMO-CSB, we identified multiple RNA
polymerase-associated factors that were not previously de-
scribed to bind to CSB, including polymerase I transcript
release factor (PTRF). PTRF is involved in termination and
re-initiation of RNA polymerase I transcription (40,41).
Consistently, CSB is a known regulator of RNApolymerase
I transcription (42). Furthermore, we identified MTA1, a
member of the NURD complex to have a preference for
SUMO-CSB. Other subunits of the NURD complex bound
unmodified CSB equally well (Figure 4E).
SUMO-Interaction Motifs (SIMs) enable non-covalent
interaction between SUMOylated proteins and readers.
These SIMs have been defined as SIMa, [PILVM]-[ILVM]-
X-[ILVM]-[DSE](3), SIMb, [PILVM]-[ILVM]-D-L-T or
SIMr, [DSE](3)-[ILVM]-X-[ILVMF](2) by Vogt and Hof-
mann (43). PTRF and MTA1 are missing these SIMs. Of
note, this is no formal proof that they cannot bind SUMO.
Interestingly, we found that the RNApolymerase subunit
PolR2H (Rbp8) and PCNA have a preference for unmodi-
fiedCSB. PolR2Hmight represent the elongatingRNAPIIo
to which CSB is known to bind. PCNA is a crucial com-
ponent of TC-NER, as it is responsible for the recruitment
of the gap-filling DNA polymerases (44,45). In conclusion,
our data suggest that SUMOylation of CSB alters its pro-
tein interactions including to RNA polymerase associated
proteins, which could contribute to efficient TC-NER.
CSA destabilizes SUMOylated CSB
Another well-described function of SUMOylation is
the destabilization of target proteins by recruitment of
STUbLs, leading to the subsequent ubiquitination and
proteasomal degradation of the SUMO-target protein.
Interestingly, the WD repeat protein CSA that is re-
cruited to UV-induced DNA lesions in a CSB-dependent
manner (46), was shown to be a substrate receptor of a
Cullin/RING (CRL) ubiquitin E3 ligase complex and
was previously proposed to target CSB for ubiquitination
(21,47). Therefore, we investigated the influence of the
CSA–CRL complex on CSB SUMOylation. To this end,
we employed U2OS cells stably expressing His-tagged
SUMO2 to enable SUMO2 purification. CSA was knocked
down using an shRNA-based approach (Supplementary
Figure S6). These cells were treated with UV irradiation or
were left untreated as indicated. Subsequently, cells were
lysed 1, 3 or 6 h after UV irradiation and SUMOylated
proteins were enriched by Ni-NTA pulldown. As shown in
the middle panel of Supplementary Figure S6, efficient and
equal SUMO enrichment was confirmed by immunoblot-
ting. In the fourth panel, CSA knockdown was confirmed
by immunoblotting. The top panel shows that one set of
CSA knockdown cells showed considerably higher levels of
SUMOylated CSB compared to parental U2OS cells and
one set of CSA knockdown cells did not.
To further investigate a potential role for CSA in reg-
ulating the levels of SUMOylated CSB, we employed
a CRISPR-Cas9-based knockout approach (Figure 5A).
Deletion of CSA was verified by immunoblotting (Figure
5B). Efficient enrichment of SUMOylated proteins from
U2OS cells expressingHis10-SUMO2was confirmed by im-
munoblotting (Figure 5A bottom panel). This panel also
shows accumulation of SUMOylated proteins in response
to proteasome inhibition, particularly in lanes 8, 11 and 14.
The top panel of this figure shows that SUMOylated CSB
could be detected in response to UV treatment. In the ab-
sence of CSA, SUMOylated CSB accumulated to a higher
extent at all three timepoints, compared to CSA wild-type
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Figure 4. SUMOylation of CSB influences binding to RNA polymerase associated proteins. (A) Schematic overview of experimental set-up. GST tagged
truncated CSB protein (aa 1–341) and SUMOmachinery were co-expressed inE. coli and subsequently purified with glutathione resin. The resulting sample
was split in two equal aliquots and one aliquot was treated with SENP2 overnight. De-SUMOylated and SUMOylated truncated CSB were incubated with
lysates of UV-treated CS1AN cells. After incubation and washing, proteins were trypsinized on the resin and peptides were analysed by mass spectrometry.
(B) Coomassie stain showing SUMOylated truncated CSB, unmodified truncated CSB and GST control. (C) The table shows a summary of identified
proteins. Putative bindings partners are defined as proteins that are significantly different between non-SUMOylated CSB and SUMOylated CSB samples
and are also significantly enriched compared to the GST control. (D) Volcano plot showing relative LFQ intensities of proteins in SUMOylated CSB
samples compared to deSUMOylated CSB samples. Dashed lines indicate a cut-off of 1.5-fold change (log2 of 0.66) and a P-value of 0.05 (–log10 of 1.3).
Putative differential binding partners which are also enriched compared to the GST control are marked in blue. Proteins that function as internal control
are marked in green. In text discussed proteins are marked in red. (E) Volcano plots showing relative LFQ intensities of proteins in deSUMOylated CSB
samples compared with GST controls (left panel) or SUMOylated CSB samples compared with GST controls (right panel). Proteins that function as
internal controls are marked in green. Proteins discussed in the text are marked in red.
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Figure 5. CSA destabilizes SUMOylated CSB. (A) U2OS WT and CSA-deficient cells stably expressing His10-SUMO2 were used to study whether CSA
affects the SUMOylation of CSB. These cells were subjected to UV irradiation (20 J/m2) and/or proteasomal inhibition (MG132) as indicated. Cells
were lysed 1, 3, or 6 h after UV irradiation. Subsequently, SUMOylated proteins were purified from these lysates by Ni-NTA pulldown. SUMO-enriched
fractions (PD) and total lysates were analysed by immunoblotting using antibodies against CSB or SUMO2/3. *marks full-length CSB; ** marks the
CSB-piggyBac transposable element derived 3 fusion (CPFP). (B) Immunoblotting to confirm the absence of CSA in U2OS cells established by CRISPR-
targeting the CSA gene. (C) CSA-deficient CS3BE patient cells and a derivate cell line that was rescued by introducing CSA-Flag were used to study whether
CSA affects ubiquitination of CSB. His10-ubiquitin was stably expressed in these cells as indicated and cells were treated overnight with cycloheximide
to prevent new protein synthesis. The next day, cells were UV irradiated (20 J/m2) and/or treated with MG132 as indicated. Ubiquitinated proteins were
purified by His10-purification. Total lysates and ubiquitin-enriched (PD) fractions were analysed by immunoblotting using antibodies against CSB, CSA
or Ub as indicated.
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cells. The reduction in SUMOylation due to the presence of
CSA could not be reversed by blocking proteasomal degra-
dation as shown in lanes 8, 11 and 14. In response toMG132
treatment, SUMO and ubiquitin are trapped on the targets
that can be no longer degraded and the pools of free SUMO
andubiquitinwill concomitantly decrease.Due to these lim-
ited pools of free SUMO and ubiquitin, less SUMO and
ubiquitin will be available for conjugation to new target pro-
teins. As a result, the SUMOylation and ubiquitination lev-
els of proteins that are not degraded by the proteasome will
decrease. This appears to be the case for SUMOylated CSB
in response to MG132 at 1 h and 6 h post UV. These results
indicate that the CSA–CRL complex regulates the stability
of SUMOylated CSB in response to DNA damage directly
or indirectly in a proteasomal-independent manner.
CSA stimulates ubiquitination of RNA polymerase II but not
CSB after UV irradiation
Following the observation that CSA influenced the destabi-
lization of SUMOylatedCSB,we testedwhetherCSAmight
target SUMOylated CSB for ubiquitination and would
therefore act as a STUbL. To evaluate this, we investigated
the influence of CSA and UV irradiation on the ubiquitina-
tion of CSB. CSA-Flag was reintroduced in the CS3BE cells
described above and these cells were engineered to stably
express His10-ubiquitin. To decrease background ubiquiti-
nation of CSB that could arise from misfolding of this 1493
amino acid long protein during protein synthesis since a sig-
nificant percentage of newly synthesized proteins are mis-
folded (48,49), we treated the cells overnight with the trans-
lation inhibitor cycloheximide. We next irradiated the cells
with UV light, lysed 2 h post-UV irradiation and purified
ubiquitinated proteins. Efficient purification of ubiquitin
and accumulation of ubiquitinated proteins in response to
proteasome inhibition were confirmed by immunoblotting
(Figure 5C, third panel). The absence of CSA inCS3BE and
presence of CSA in the rescued cells were also confirmed by
immunoblotting (Figure 5C, bottom panel). Next, we tested
whether CSB ubiquitination was enhanced in the presence
of CSA and we confirmed that this was the case (Figure
5C, top panel). However, CSA-dependent ubiquitination
of CSB was already detectable in unirradiated cells (Fig-
ure 5C, lanes 1–6) and was reduced rather than enhanced
upon UV treatment (Figure 5C, lanes 7–12). Inhibiting the
proteasome did not result in an accumulation of ubiquiti-
nated CSB, although total ubiquitin conjugates increased
as expected (Figure 5C). The destabilization of SUMOy-
lated CSB can therefore not be explained by UV-induced
CSA-dependent ubiquitination. Furthermore, ubiquitina-
tion of CSB does apparently not cause subsequent protea-
somal degradation.
We next hypothesized that the observed UV- and CSA-
dependent destabilization of SUMOylated CSB shown in
Figure 5A, is an indirect effect of a ubiquitination event of
another unknown protein. Therefore, we set out to identify
possible UV-induced ubiquitination targets of CSA in an
unbiased manner. We used CSA-deficient CS3BE cells sta-
bly expressing His10-ubiquitin with or without exogenous
expression of CSA-Flag. Cells were stable isotope labelled
by amino acids in cell culture (SILAC) as described in the
upper panel of Figure 6A. Cells were treated in four differ-
ent manners, including no UV irradiation, UV irradiation
in combination with 1 h recovery (short recovery), or 6 h re-
covery (long recovery) and 6 h recovery combined with pro-
teasome inhibition. Differential ubiquitination of proteins
was analysed by mass spectrometry for each of the four dif-
ferent treatments (Figure 6A). Ubiquitination of CSB was
not detected in this screen. Most intriguingly, we identi-
fied the largest RNAPII subunit, RPB1, as a differentially
ubiquitinated protein 1 h after UV irradiation in a CSA-
dependent manner. This ubiquitination of RPB1 was not
detected after the 6 h recovery, but stabilized upon protea-
some inhibition, indicating a CSA-dependent destabiliza-
tion of RPB1 (Figure 6A, Supplementary Table S4).
Subsequently, we carried out experiments to verify our
proteomics data, using immunoblotting analysis of His10-
ubiquitin-enriched fractions (Figure 6B). In the third panel
of Figure 6B, His10-ubiquitin enrichment was confirmed in
the stably expressing CS3BE cells as expected. The same
panel shows that ubiquitin was stabilized by proteasome
inhibition as expected. The bottom panel of Figure 6B
confirms the presence of CSA-Flag in the rescued CS3BE
cells. The second panel confirms the presence of elongat-
ing RPB1 (p-RPB1) in all samples. This is the relevant form
of RPB1 in this context. Next, we asked whether p-RPB1
is a substrate for ubiquitination following UV irradiation,
and whether that is dependent on CSA and leads to pro-
teasomal degradation. This is shown in the top panel of
the Figure. In CS3BE cells lacking His10-ubiquitin, no p-
RPB1 is detected, showing correct negative controls. Inter-
estingly, ubiquitination of p-RPB1 is only detected in re-
sponse to UV damage. Cells expressing CSA have consid-
erably more ubiquitinated p-RPB1. This is unlikely due to
loading errors as shown in the second and third panels of
this figure. At 6 h post irradiation, the ubiquitination sig-
nal of p-RPB1 diminishes, presumably due to degradation
of the ubiquitinated p-RPB1. This is supported by the re-
sults in lanes 9 and 10 in which the proteasomal inhibitor
MG132 is present. In conclusion, these results confirm our
proteomics results that CSA regulates ubiquitination of p-
RPB1 in response to UV damage. In the absence of CSA,
some ubiquitination of p-RPB1 in response to UV damage
was still noticeably, indicating that UV-induced ubiquitina-
tion of elongating RPB1 in response to UV partly occurs in
a CSA-independent manner.
Next, we carried out a similar experiment as described
in Figure 6B, now using U2OS cells proficient or deficient
for CSA (Figure 6C). This experiment confirms our results
obtained in Figure 6A and B, strengthening the conclu-
sion that CSA regulates the ubiquitination of p-RPB1 in re-
sponse to UV damage. Using the samples shown in Figure
6C and staining them for RPB1 ubiquitination, we noticed
that after a short recovery (1 h) uponUV irradiation, RPB1
was ubiquitinated in a CSA-dependent manner in U2OS
cells but not subjected to proteasomal degradation as treat-
ment with proteasome inhibitor did not result in an accu-
mulation of ubiquitinated RPB1 (Figure 6C). However, af-
ter a longer recovery time of 6 h, proteasome inhibition sta-
bilized ubiquitinated RPB1. Nevertheless, in the total lysate
controls, the proteasome inhibitor does not rescue the levels
of RPB1 and p-RPB1, indicating that proteasomal degra-
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Figure 6. CSA stimulates ubiquitination of RNA polymerase II in a UV-dependent manner. (A) CS3BE cells with or without ectopic expression of CSA-
Flag and stably expressing His10-ubiquitin were SILAC labelled and subjected to UV irradiation (20 J/m2) and/or treated with MG132 or were left
untreated as indicated. Cells were lysed 1 or 6 h after UV irradiation. Ubiquitinated proteins were purified by Ni-NTA pulldown. Eluted proteins were
trypsinized and analysed by mass spectrometry. The table shows an overview of experimental conditions and the log2 medium/heavy ratios of the RNAPII
subunit RPB1 in each experiment. (B) CS3BE cells with or without ectopic expression of CSA-Flag and stably expressing His10-ubiquitin were treated
with UV irradiation (20 J/m2) and MG132 where indicated and lysed after the indicated recovery times. Total lysates and ubiquitin-enriched fractions
(PD) were analysed by immunoblotting using antibodies against p-RBP1 (S2/S5), His or CSA. (C) U2OS w.t. and CSA-deficient cells stably expressing
His10-ubiquitin were subjected to UV irradiation (20 J/m2) and/or proteasomal inhibition (MG132) or were left untreated as indicated. Cells were lysed 1,
3 or 6 h after UV irradiation. Ubiquitinated proteins were purified by Ni-NTA pulldown. Ubiquitin-enriched fractions and total lysates were analysed by
immunoblotting using antibodies againstRPB1, p-RPB1 (S2/S5) or ubiquitin. *residual p-RPB1 (S2/S5) signal in blot re-probed with ubiquitin antibody.
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dation of RPB1 at the 6 h timepoint is limited. Collectively,
these results indicate that CSA is stimulating the ubiquiti-
nation of RNAPII either directly or indirectly upon UV ir-
radiation, leading to proteasomal degradation of a subset of
RNAPII only after a longer recovery upon the DNA dam-
age.
DISCUSSION
Link between CSA, ubiquitinated RNAPII and SUMOy-
lated CSB
Mutations in theCSA andCSB genes give rise to Cockayne
Syndrome, a severe neurodegenerative and premature aging
disorder that is associated with hypersensitivity to UV irra-
diation, primarily due to defects in TC-NER. CSA is the
substrate recognition factor of an E3 Cullin ubiquitin lig-
ase complex. However, it is currently unclear which proteins
are targeted for CSA-dependent ubiquitination at sites of
DNAdamage. CSB has been suggested as aUV-specific tar-
get for CSA mediated ubiquitination and subsequent pro-
teasomal degradation (21). Although we observed an in-
crease in CSB ubiquitination in a CSA-dependent manner,
this was not induced and even slightly reduced in response
to UV irradiation and ubiquitinated CSBwas not stabilized
in response to proteasome inhibition. Of note, the usage
of tagged-ubiquitin constructs precludes the detection of
potential linear ubiquitin chains on CSB. Nevertheless, in
our hands it does not appear that CSB is a target for UV-
dependent degradation via the CSA–CRL E3 ligase com-
plex. However, we did find that the recruitment of this com-
plex is responsible for the destabilization of SUMOylated
CSB after UV. Our observation provides a novel link be-
tween CSB and CSA, but raises the question how CSA is
regulating the destabilization of SUMOylated CSB.
A potential explanation for the destabilization of
SUMOylated CSB by the CSA–CRL complex is the ubiqui-
tination of other targets by this complex. We identified the
RNAPII subunit RPB1 as a key target for the CSA com-
plex. Ubiquitination of RPB1 directly or indirectly by the
CSA complex could potentially induce the dissociation of
CSB from chromatin and its translocation to the nucleo-
plasm where it can be deSUMOylated by SUMO-specific
proteases (Figure 7). Intriguingly, RNAPII ubiquitination
and degradation is believed to be a ‘last-resort’ response to
DNA damage (50). In contrast to CSB, we could observe
CSA-dependentUV-induced ubiquitination of theRNAPII
subunit RPB1. However, we could only observe a stabiliza-
tion of the ubiquitinated RPB1 upon inhibition of the pro-
teasome at a later timepoint (6 h) post-UV irradiation, indi-
cating a ubiquitination event that does not immediately lead
to degradation. Also we observed that there is a significant
residual UV-induced ubiquitination of RNAPII in CS3BE
cells lacking CSA, which indicates the presence of other
ubiquitin E3 ligases targeting RNAPII. CSA-independent
ubiquitination of RPB1 could be regulated by the E3 lig-
ases NEDD4 and the Elongin A,B,C complex (51). These
E3 ligases play important roles at the early stage after UV
irradiation, within 30 min, and mediate K63-linked ubiqui-
tin chains.
Intriguingly, it was previously found that CSB contains a
ubiquitin binding-domain (UBD) that is required for TC-
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Figure 7. SUMO and ubiquitin cooperate during TC-NER. The process-
ing RNAPII is stalled upon encountering a DNA photolesion with helix
distorting property, which is introduced by UV light, MMS or etoposide
within an actively transcribedDNA region. In response to the stalledRNA
polymerase, CSB is SUMOylated, recruited and stabilized at the lesion site.
CSA is subsequently recruited to the site of damage and stimulates ubiq-
uitination of RNAPII directly or indirectly. After a short recovery upon
DNA damage, SUMOylated CSB is destabilized by the presence of CSA.
The proteasomal degradation of ubiquitinated RNAPII is observed at a
late stage (6 h) after UV irradiation, possibly related to failure of repair.
NER (52). If this observation is connected to our findings,
CSA-dependent ubiquitination of RNAPII might provide
a docking site for the UBD in CSB. Subsequent release or
degradation of ubiquitinated RNAPII might result in co-
release or degradation of CSB. The UBD domain of CSB is
not required for its SUMOylation (53). Whether the UBD
domain is required for the clearance of SUMOylated CSB
is currently unclear. Follow-up projects could focus on the
potential connection between CSB SUMOylation, its UBD
domain and RNAPII ubiquitination. An alternative expla-
nation for the observed effect would be that the degrada-
tion of other proteins is required for the destabilization of
SUMOylated CSB.
SUMO group modification in response to UV
The SUMOylation of CSBwas described in a previous pub-
lication, which reported lysine 205 as major SUMOylation
site (53). We could confirm this finding but additionally
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found a contribution of lysine 32 to SUMOylation of CSB.
To evaluate the functional importance of K32 SUMOyla-
tion, we studied the recruitment of WT, the single mutants
K205R and K32R and the 2KR CSB mutant to local UV
lesions and observed that mutating both N-terminal lysines
of CSB impaired the recruitment to the local UV-induced
damage more effectively than the single mutation of K205,
showing a functional contribution of K32 if K205 is not
available for SUMOylation.
We could further confirm that SUMOylation and the two
N-terminal SUMOylation sites in CSB contribute to RRS
after UV damage. This is in line with the previous publica-
tion showing the effect of UBC9 (SUMO E2-conjugating
enzyme) knockdown on RRS (53). Because CSB was the
only TC-NER protein that we identified in our mass spec-
trometry screen to be SUMOylated in response to UV,
it is likely that CSB SUMOylation contributes to this ef-
fect. Interestingly, lesion recognition in GG-NER occurs
via XPC, a well-knownUV-regulated SUMO target that we
confirmed in our screen (18–20). Thus, both branches of
NER involve lesion recognition factors that are regulated
by SUMO.
Our results linking reduced levels of SUMOylated CSB
to the presence of CSA are in contrast to this previous pub-
lication (53). This could potentially be due to differences in
SUMO-enrichment methodology between both studies. We
prefer highly efficient enrichment ofHis10-tagged SUMOy-
lated proteins usingNiNTAbeads, which is compatible with
the use of strongly denaturing buffers to inactivate endoge-
nous SUMO proteases, whereas the previously published
study employed immunoprecipitation, necessitating the use
of milder buffer conditions to prevent denaturation of the
employed antibodies.
Althoughwe did not identify any other obvious TC-NER
proteins as UV-responsive SUMO2 targets, we did identify
dynamic SUMOylation in response to UV irradiation of
proteins associated with transcription, like the TFIID basal
transcription factor components TAF1, TAF5, TAF6 and
TAF12. This observation suggests that the transcription re-
sponse to elongation-blocking DNA lesions is in part con-
trolled through SUMOylation. These results further high-
light the SUMO group-modification concept, where mod-
ification of a set of targets within a biological pathway is
needed for stronger biological effects, as was observed in the
context of DSB repair (54). Our results indicate that SUMO
co-regulates a considerably larger set of targets in response
to UV irradiation compared to IR.
Model
Taken together we suggest a model wherein CSB is
SUMOylated and recruited to UV lesion-stalled RNAPII.
This association recruits the CSA–CRL complex to the site
of damage, where it stimulates the ubiquitination of the
RNAPII subunit, RPB1 in a direct or indirect manner. The
activity of CSA initiates the release of SUMOylated CSB,
but CSA does not act as a STUbL for SUMOylated CSB.
Ubiquitinated RPB1 resides at the site of the lesion until the
lesion is either repaired or in case repair failed, it would trig-
ger the proteasomal degradation of RPB1. Our data fit well
with initial observations in the field on reducedUV-induced
ubiquitination of RPB1 in fibroblasts fromCS patients (55).
Overall our results provide new insights in the cooperative
signaling roles for SUMOylation and ubiquitination of TC-
NER components. Whereas CSB is a prime SUMO2 tar-
get, the stability of SUMOylated CSB and the ubiquitina-
tion of RPB1 is dependent on CSA. Combined, these two
small modifiersmay contribute toRRS, presumably via effi-
cient TC-NER and transcription restart in response to UV
irradiation. Furthermore, we identified an extensive set of
SUMOylated proteins in response to UV irradiation. De-
tailed functional analysis of these proteins will improve our
understanding of the role of SUMO group modification in
the cellular response to UV irradiation.
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